(Q39292641)

English

ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms

scientific article published on 23 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1 reference

based on heuristic

inferred from title

author name string

Hee Jin Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Hyang Sook Seol

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Joo Young Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sung-Min Chun

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Young-Ah Suh

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Young-Soo Park

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sang-we Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Chang-Min Choi

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Seung-Il Park

9

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Dong Kwan Kim

10

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Yong-Hee Kim

11

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Se Jin Jang

12

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

23 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

200-208

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Expression and rearrangement of the ROS1 gene in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Analysis of oncogene expression in primary human gliomas: evidence for increased expression of the ros oncogene

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Diversity of gene expression in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

ROS1 rearrangements define a unique molecular class of lung cancers

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Heterologous transmembrane signaling by a human insulin receptor-v-ros hybrid in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Two chimeric receptors of epidermal growth factor receptor and c-Ros that differ in their transmembrane domains have opposite effects on cell growth

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Stat3 plays an important role in oncogenic Ros- and insulin-like growth factor I receptor-induced anchorage-independent growth

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Rho GTPases: signaling, migration, and invasion

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Design, synthesis, screening, and molecular modeling study of a new series of ROS1 receptor tyrosine kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Expression and localization of c-ros oncogene along the human excurrent duct

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Demethylation of MAGE promoters during gastric cancer progression

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2553-6

21 January 2018

Identifiers

10.1245/S10434-012-2553-6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Dimensions Publication ID

0 references

release_x66ntsv2qfgwvcboalofufmpau

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39292641&oldid=2202753885"